Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MiWear

Financiado

Mid-infrared Wearable for Non-invasive biomarker monitoring

Modern medicine has improved dramatically through a better understanding of what causes a condition or what it is correlated to. However, the healthcare system still follows an episodic (reactive) model, where patients only seek m... ver más

31/12/2026

QUANTUNE TECHNOLOG...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

QUANTUNE TECHNOLOGIES GMBH No se ha especificado una descripción o un objeto social para esta compañía.

Ver 6 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-12-13

HORIZON-EIC-2022-PATHFINDERCHALLENGES-01-04: EIC Pathfinder Challenge: Towards t... Scope:Today, episodic (symptom-triggered) healthcare remains the norm. To a large extent, individual...

I+D

Cerrada hace 2 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

QUANTUNE TECHNOLOGIES GMBH

1.17M€ | Lider

JOANNEUM RESEARCH

1.00M€ | Participante

SCIENCE&STRATEGY SL

376.56K€ | Participante

ASOCIATIA TRANSYLVANIAN INST...

555.75K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

EUIN2015-62503 SISTEMA ELECTRONICO PORTATIL PARA ALERTAR SOBRE LA OCURRENCI... 25K€ Cerrado

FJC2018-038277-I Biomarcadores no invasivos de salud y bienestar 50K€ Cerrado

Lassie Lassie: The first-ever painless breath analyser for people w... 11M€ Cerrado

DVD-E DVD-readable opto-electrochemical Lab-on-a-Disc as small-fac... 278K€ Cerrado

SensCare AI-based wearable sensors for continuous monitoring of diabe... 75K€ Cerrado

NoOne A binary sensor with single-molecule digit to discriminate b... 2M€ Cerrado

Duración del proyecto: 36 meses Fecha Inicio: 2023-12-13
Fecha Fin: 2026-12-31

Líder del proyecto

QUANTUNE TECHNOLOGIES GMBH No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 4M€

Descripción del proyecto Modern medicine has improved dramatically through a better understanding of what causes a condition or what it is correlated to. However, the healthcare system still follows an episodic (reactive) model, where patients only seek medical advice when there are symptoms, which, for certain medical conditions, has proven critically insufficient. In this context, one of the main burdens for our socioeconomic system in Europe by a single disease is without question the metabolic syndrome (MbS). MbS is prominently visible in the large and ever-growing number of overweight or obese individuals. Yet, its true negative dramatic consequences among others are arteriosclerosis, hereby induced myocardial infarction, and stroke. Several biomarkers such as uric acid, albumin, or ketone bodies correlate with MbS and often indicate different aspects of the metabolic syndrome. The more biomarkers can be measured and quantified with high accuracy, the easier it becomes to make conclusive decisions on the patient’s status. False negatives as well as false positives can be avoided much better with more parameters – if each of them is measured individually and directly without the need for indirect methods where evaluations are easily overfitted. We provide an alternative approach for the measurement of biomarkers, using a miniatured Mid-Infrared spectrometer, a technology that is only used in laboratories due to its size and cost. The result of the project will be a wearable device to detect biomarkers non-invasively and pain-free in the interstitial fluid in the skin. For MiWear, we have gathered an impressive consortium combining expert knowledge on biomarkers, optical spectroscopy, laser physics, business management, finances, and the gender dimension of biomarkers. During the project, we will generate opportunities for young researchers, and engage with different stakeholders to ensure maximum outreach of our research and development activities.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores